Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 41788 | CB-6644 | 2316817-88-4 | 96.33% |  |
| CB-6644 acts as a noncompetitive ATPase inhibitor. Additionally, it can inhibit RUVBL | ||||
| 20111601 | Coralyne chloride | 38989-38-7 | 98% Min. |  |
| Coralyne chloride is a a protoberberine alkaloid, can be used as a fluorescent DNA-ba | ||||
| 20103005 | 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | 958230-19-8 | ≥97% |  |
| 2091502 | 5-(chloromethyl)-1-propyl-1H-imidazole hydrochloride | 497223-15-1 | ≧95.0% | -1-propyl-1H-imidazole_hydrochloride_497223-15-1.png) |
| 5-(chloromethyl)-1-propyl-1H-imidazole hydrochloride is an important intermediate of | ||||
| 2091202 | 2-chloro-4-(4-fluorophenyl)thiazole-5-carbonitrile | 1628265-17-7 | 98% Min. | thiazole-5-carbonitrile_1628265-17-7.png) |
| 2071556 | CL2A-SN38 DCA | 1279680-68-0 | 98% Min. |  |
| CL2A-SN38 is a SN38 derivative with a peptide-linker which can easily react with anti | ||||
| 2071544 | Cariprazine HCl | 839712-12-8 | 98% Min. |  |
| Cariprazine, also known as RGH-188 and MP-214, is an antipsychotic drug received FDA | ||||
| 2071538 | CM-272 | 1846570-31-7 | 98% Min. |  |
| CM-272 is a first-in-class reversible dual small molecule inhibitor against G9a and D | ||||
| 2062317 | 2-Cyano-4-fluorobenzaldehyde | 77532-90-2 | 98% Min. | |
| 2062306 | 3-chloro-1-benzothiophene-2-carbonyl chloride | 21815-91-8 | 98% Min. | |
| 2062026 | 5-chloro-2,6-dimethoxy-4-methyl-8-nitroquinoline | 189746-21-2 | 96% Min. |  |
| 2062022 | 4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7-methoxyquinazoline | 612501-52-7 | 96% Min. | -6-hydroxy-7-methoxyquinazoline_612501-52-7.png) |
| 2062014 | 2-chloro-6-methoxy-4-methylquinoline | 6340-55-2 | 96% Min. |  |
| 2061702 | CaCCinh-A01 | 407587-33-1 | 98% Min. |  |
| CaCCinh-A01, also known as TMEM16 Blocker I, is a TMEM16 Blocker. CaCCinh-A01 is a no | ||||
| 615201 | CLEFMA | 1246964-32-8 | 98% Min. |  |
| CLEFMA has anti-proliferative activity in H441 cells. CLEFMA may induce autophagic ce | ||||
| 2061307 | CMPD1 | 41179-33-3 | 98% Min. |  |
| CMPD1 is an inhibitor of MK2 activation, primarily inhibiting tubulin polymerisation | ||||
| 2061306 | CGP52411 | 145915-58-8 | 98% Min. |  |
| CGP52411, also known as DAPH, is a selective inhibitor of the epidermal growth factor | ||||
| 2051505 | CADD522 | 199735-88-1 | 98% Min. |  |
| CADD522 is a potent inhibitor of runt-related transcription factor-2 (RUNX2)-DNA bind | ||||
| S-204160 | 2-Chloro-7-fluoro-quinoline-3-carbaldehyde | 745830-16-4 | 98% Min. |  |
| S-203042 | cupreine | 524-63-0 | 98% Min. |  |
| 2041501 | CC-885 | 1010100-07-8 | 98% Min. |  |
| CC-885 is a potent Cereblon Modulator with potent antitumor activity mediated through | ||||
| 203071 | CC-90009 | 1860875-51-9 | 98% |  |
| CC-90009 is a modulator of cereblon (CRBN), which is part of the cullin 4-RING E3 ubi | ||||
| 4281903 | 5-Chloro-2,6-Dimethoxy-4-Methylquinoline | 189746-19-8 | >96% |  |
| 5-Chloro-2,6-Dimethoxy-4-Methylquinoline, CAS 189746-19-8, is a key drug intermediate | ||||
| S510901 | Cenicriviroc Mesylate | 497223-28-6 | 98% Min. |  |
| Cenicriviroc (CVC) is an oral, once-daily, potent immunomodulator that blocks two che | ||||
| 193286 | CLP-290 | 1181083-81-7 | >98% |  |
| CLP-290 is a novel KCC2 modulator and prodrug of CLP-257, highly selective for KCC2 o | ||||
| 193181 | Clofilium Tosylate | 92953-10-1 | >98% |  |
| Clofilium Tosylate is a K+ channel blocker, cardiac depressant, and anti-arrhythmic a | ||||
| 193124 | Cevipabulin fumarate | 849550-67-0 | >98% |  |
| Cevipabulin fumarate (TTI-237 fumarate) is an oral active, microtubule-active antitum | ||||
| 19342 | Conteltinib | 1384860-29-0 | >98% |  |
| Conteltinib is a tyrosine kinase inhibitor and an antineoplastic. | ||||
| 192274 | C25-140 | 1358099-18-9 | >98% |  |
| C25-140 is the first in class protein-protein interaction inhibitor of a RING-E3 liga | ||||
| 192192 | CCT-137690 | 1095382-05-0 | >98% |  |
| CCT137690, an aurora kinase inhibitor CCT137690, is a highly selective, orally bioava | ||||